.
MergerLinks Header Logo

Announced

Rite Aid rejected a $3.6bn offer from Spear Point Capital.

Financials

Edit Data
Transaction Value£2,759m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium56%
One Off Charge-

Tags

Edit

Friendly

Domestic

drugstore operator

Drug Retailers

United States

Acquisition

Single Bidder

Private Equity

Majority

Public

Pending

Privatisation

Synopsis

Edit

Rite Aid, an American drugstore chain, rejected a $3.6bn offer from Spear Point Capital Management, a private equity firm. Rite Aid's board said the proposal was not credible as it had no evidence of financing and required multiple months of exclusivity, among other reasons.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US